Outcome of ATT at 6 months/completion | |||
---|---|---|---|
Outcome | Early ART (n = 88) | Delayed ART (n = 62) | P value |
Successfully treated | 93.4% (71/76) | 93.1% (54/58) | 0.105 (Overall) |
Failure | 6.6% (5/76) | 5.2% (3/58) | |
Treatment Modified | 1.3% (1/76) | 1.7% (1/58) | |
Losses during ATT: | |||
Died | 06 (6.8%) | 04 (6.4%) | |
Lost to Follow Up | 06 (6.8%) | 00 (0.0%) | |
Outcome of ART at 12 months | |||
Outcome | Early ART (n = 88) | Delayed ART (n = 62) | P value |
HIV Disease Progression | 14 (16%) | 19 (31%) | 0.045 |
Clinical Failure | 00 (0%) | 01 (1.6%) | 0.413 |
Immunological failure | 08 (9.1%) | 14 (22.6%) | 0.033 |
Virological failure | 08 (09.1%) | 08 (12.9%) | 0.592 |
Lost to follow up | 11 (12.5%) | 01 (1.6%) |